Loading the company…
Loading the company…
Families: Bone graft & orthobiologics, Lumbar fusion, Skin substitutes & wound grafts.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Berkeley Advanced Biomaterials (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2026 (1). The latest was on 2026-08-27.
| Family | Decisions on record |
|---|---|
| Bone graft & orthobiologics | 14 |
| Lumbar fusion | 14 |
| Skin substitutes & wound grafts | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-08-27 | 510(k) | K260711 | Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP) |
| 2017-10-30 | 510(k) | K170917 | Bi-Ostetic Bioactive Glass Foam |
| 2012-03-15 | 510(k) | K113791 | B-GENIN, R-GENIN |
| 2010-06-23 | 510(k) | K091912 | B-GENIN AND R-GENIN |
| 2010-03-24 | 510(k) | K092046 | BI-OSTETIC FOAM AND PUTTY, GENEROS FOAM AND PUTTY |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Berkeley Advanced Biomaterials.